A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
Clinical trial NCT07550387 · COMPLETED
Trial details
- NCT number
- NCT07550387
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-23
- Primary completion
- 2026-01-02
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.